Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA
March 29, 2024
By: Aaron Savit, and Ian Swan*
FDLI’s Update Magazine, Spring 2024 Issue
Axinn associates Aaron Savit and Ian Swan co-authored the article "Chevron Deference on the Brink: Small Fish May Mean Big Changes for FDA," published in the Spring 2024 issue of the Food and Drug Law Institute's Update magazine.
Click here to access the article. Shared with the permission of FDLI.
Click here to access the Spring 2024 issue of Update magazine.
*Not yet admitted to the Washington, DC Bar.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
National Bar Association 100th Annual Convention and Exhibits
Sponsorship
Antitrust
Keeping Pace: Updates in Cartel Enforcement
Webinar
Antitrust
GCR Live: Law Leaders Europe 2025
Speaking Engagement
Antitrust
Navigating the Hart-Scott-Rodino Act in 2025
Webinar
Antitrust
AHLA Annual Meeting 2025
Speaking Engagement
Antitrust
State by State, Pre-Merger Notifications Expand
Axinn Viewpoints
Antitrust
FTC claims diverging market from EU in Mars/Kellanova clearance
Media Mentions
Keeping an Eye on the Ball: America First Antitrust Weighs in on the “Uniquely American System of Scholar Athletics”
Axinn Viewpoints
Antitrust
Wait, We Have To Tell Who? What You Need To Know About State Premerger Notifications
Podcast
MBK | MSK Fellowship Summit 2025
Sponsorship
Antitrust